171 related articles for article (PubMed ID: 3861247)
1. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.
Gockerman JP; Raney M; Logan T
Cancer Treat Rep; 1985 Sep; 69(9):1029-30. PubMed ID: 3861247
[No Abstract] [Full Text] [Related]
2. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
[No Abstract] [Full Text] [Related]
3. Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial.
Gockerman JP; Silberman H; Bartolucci AA
Cancer Treat Rep; 1987; 71(7-8):773-4. PubMed ID: 3300970
[No Abstract] [Full Text] [Related]
4. Phase II study of aclarubicin in previously untreated patients with advanced soft tissue sarcoma: a Southeastern Cancer Study Group trial.
Bertrand M; Multhauf P; Bartolucci A; Ellison D; Gockerman J
Cancer Treat Rep; 1985 Jun; 69(6):725-6. PubMed ID: 3860295
[No Abstract] [Full Text] [Related]
5. Phase II trial of aclarubicin in advanced breast cancer: a cancer and leukemia group B study.
Forastiere AA; Budman DR; Richards F; Aisner J; Weinberg V; Wood WC
Cancer Treat Rep; 1983 Dec; 67(12):1137-8. PubMed ID: 6580949
[No Abstract] [Full Text] [Related]
6. Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Booth BW; Korzun AH; Weiss RB; Ellison RR; Budman D; Khojasteh A; Wood W
Cancer Treat Rep; 1986 Oct; 70(10):1247-8. PubMed ID: 3530455
[No Abstract] [Full Text] [Related]
7. Phase II trial of aclarubicin in epidermoid carcinoma of the head and neck.
Carugati AA; Olivari AJ; Campos DM; Pradier R; Woolley PV
Cancer Treat Rep; 1986 Jun; 70(6):799-800. PubMed ID: 3524828
[No Abstract] [Full Text] [Related]
8. Aclacinomycin. Phase II evaluation in advanced squamous carcinoma of the head and neck.
Kish JA; Al-Sarraf M
Am J Clin Oncol; 1984 Oct; 7(5):535-7. PubMed ID: 6507374
[TBL] [Abstract][Full Text] [Related]
9. Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study.
Willson JK; Knuiman MW; Skeel RT; Wolter JM; Pandya KJ; Falkson G; Chang YC
Cancer Treat Rep; 1986 Oct; 70(10):1237-8. PubMed ID: 3530452
[No Abstract] [Full Text] [Related]
10. Phase II evaluation of aclacinomycin-A (NSC-208734) in adenocarcinoma of the kidney.
Decker DA; Drelichman A; Opipari MI; Al-Sarraf M
Am J Clin Oncol; 1984 Oct; 7(5):527-8. PubMed ID: 6594927
[No Abstract] [Full Text] [Related]
11. Phase II study of aclarubicin in patients with breast cancer previously untreated with adriamycin.
Kerpel-Fronius S; Gyergyay F; Hindy I; Decker A; Sawinsky I; Mechl Z; Nekulova M; Kolariĉ K; Tomek R; Röthig J
Eur J Haematol Suppl; 1987; 47():67-9. PubMed ID: 3471527
[No Abstract] [Full Text] [Related]
12. Experimental and clinical studies on aclarubicin in the treatment of solid tumors.
Kumai K; Kubota T; Ishibiki K; Abe O
Biomed Pharmacother; 1984; 38(7):332-7. PubMed ID: 6596963
[TBL] [Abstract][Full Text] [Related]
13. Clinical phase I study of aclacinomycin A by evaluation of an intermittent intravenous administration schedule.
Casper ES; Gralla RJ; Young CW
Cancer Res; 1981 Jun; 41(6):2417-20. PubMed ID: 6940656
[TBL] [Abstract][Full Text] [Related]
14. Phase II evaluation of aclacinomycin A (ACM-A, NSC208734) in patients with metastatic colorectal cancer.
Bedikian AY; Stroehlein J; Korinek J; Karlin D; Valdivieso M; Bodey G
Am J Clin Oncol; 1983 Apr; 6(2):187-90. PubMed ID: 6572470
[TBL] [Abstract][Full Text] [Related]
15. [Aclarubicin in metastatic thyroid cancer: initial clinical experience].
Langsteger W; Lind P; Eber O; Költringer P; Klima G
Radiobiol Radiother (Berl); 1988; 29(2):243-5. PubMed ID: 3165198
[No Abstract] [Full Text] [Related]
16. Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Booth BW; Weiss RB; Korzun AH; Wood WC; Carey RW; Panasci LC
Cancer Treat Rep; 1985; 69(7-8):919-20. PubMed ID: 3893695
[No Abstract] [Full Text] [Related]
17. The anthracycline antineoplastic drugs.
Young RC; Ozols RF; Myers CE
N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
[No Abstract] [Full Text] [Related]
18. Aclarubicin in the treatment of relapsed or resistant acute myelogenous leukaemia: a phase II trial.
Evensen SA; Wisløff F; Müller E; Talstad I; Waage A; Johansen L
Eur J Haematol Suppl; 1987; 47():43-7. PubMed ID: 3471524
[No Abstract] [Full Text] [Related]
19. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
Warrell RP; Arlin ZA; Kempin SJ; Young CW
Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
[TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of vindesine in patients with advanced breast cancer.
Currie VE; Camacho F; Wittes R; Young C
Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
[No Abstract] [Full Text] [Related]
[Next] [New Search]